PURPOSE: Colorectal cancer is the fourth most common cancer and the second leading
cause of cancer death in the United States. Accumulating evidence indicates that …

Objective: To review systematically the association between hormone replacement therapy
(HRT) and the risk of developing or dying from colorectal cancer. Data Sources: We …

Colon cancer incidence and mortality rates are lower in females compared with males, and
numerous epidemiological studies suggest that estrogen replacement therapy (ERT) …

Studies suggest that estrogen therapy (ET) and combined estrogen‐progestogen therapy
(EPT) may have different associations with colorectal cancer (CRC) risk, but data are …

We have investigated the presence of oestrogen receptor-related (ERR) mRNA in human
colorectal tumour tissues and adjacent normal mucosa by reverse transcriptase and nested …

Background: Increased body mass index (BMI) is an established colorectal cancer risk
factor. High waist circumference or waist-hip-ratio (WHR) may better reflect an abnormal …

Existing data suggest that there is a hormonal basis to the cause of colon cancer. In the
present study, we evaluated the presence of estrogen receptors (ERs) and progesterone …

Colorectal cancers are a significant cause of mortality in Western societies. The progression
of the disease from normal epithelium to the acquisition of the malignant phenotype is …

The incidence of colorectal cancer (CRC) is lower in women than in men, and sex steroids
can be considered contributing factors because oral contraception usage and estrogen …

Colorectal cancer is the third most prevalent cancer in the world. If detected at an early
stage, treatment often might lead to cure. As prevention is better than cure, epidemiological …